Results

Total Results: 3,981 records

Showing results for "cardiovascular".
Users also searched for: statin

  1. digital.ahrq.gov/sites/default/files/docs/citation/u18hs026849-dorr-final-report-2022.pdf
    January 01, 2022 - can be narrow; a large blood pressure trial, the SPRINT study, showed a 25% relative reduction in cardiovascular … management while also helping their care teams to obtain a more complete understanding of the patient’s cardiovascular … Gamified applications for secondary prevention in patients with high cardiovascular disease risk: A
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/QZ-N4vDvgZSsghretDokg7
    March 01, 2014 - control groups (ischemic heart disease [8.7% and 9.0%, respectively], stroke [2.7% for both], other cardiovascular … high-risk approach using a validated multifactorial risk cal- culator that considers family history, cardiovascular … Takagi H, Niwa M, Mizuno Y, Goto SN, Umemoto T; All-Literature Investigation of Cardiovascular Evidence
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/teeHcmNgvNBSj4-E9SN5QK
    February 01, 2005 - Potential confounding of screening trial results may also have occurred because of improved management of cardiovascular … risk for AAA depends on a variety of factors, such as age, sex, smoking history, family history, and cardiovascular … Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men.
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/exVc75LHoUdnqjY6wYxzGV
    June 01, 2003 - A recent article in the British Medical Journal questioned whether the cardiovascular and mental health … exposure might outweigh its harmful effects.84 The authors hypothesized that seasonal patterns in cardiovascular … mortality and in cardiovascular risk factors may be related to sun exposure.
  5. hcup-us.ahrq.gov/db/tools/HCUP_Formats.TXT
    December 28, 2023 - procedures on vessels other than head and neck" 62 = " 62: Other diagnostic cardiovascular … procedures" 63 = " 63: Other non-OR therapeutic cardiovascular procedures" … 34 - 42 = " 6: Proc on Respiratory System" 43 - 63 = " 7: Proc on Cardiovascular
  6. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/skin-cancer-counseling-2003
    October 06, 2003 - A recent article in the British Medical Journal questioned whether the cardiovascular and mental health … exposure might outweigh its harmful effects. 84 The authors hypothesized that seasonal patterns in cardiovascular … mortality and in cardiovascular risk factors may be related to sun exposure.
  7. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2019_IP_MaskedStats.PDF
    January 01, 2019 - PACEMAKER IMPLANT W/O CC/MCC 4,974 0.10 245: AICD GENERATOR PROCEDURES 712 0.02 246: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W MCC 6,913 0.15 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 4,592 0.10 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 1,156 0.02 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W MCC … PROCEDURES W MCC 6,914 0.15 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 4,591 0.10 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 1,156 0.02 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W MCC
  8. www.ahrq.gov/sites/default/files/2024-01/aparasu-report.pdf
    January 01, 2024 - The medications included use of cardiovascular agents and psychotropic agents (30 days before the event … cerebrovascular events, osteoarthritis, osteoporosis, and rheumatoid arthritis; co-medications like cardiovascular … Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients … Total anticholinergic burden and risk of mortality and cardiovascular disease over 10 years in 21,636
  9. digital.ahrq.gov/sites/default/files/docs/citation/cds-evaluation-summary-report-p233201500023I.pdf
    March 23, 2022 - Medicaid Services CPG-on-FHIR Clinical Practice Guidelines on FHIR CQL Clinical Quality Language CVD Cardiovascular … TISTA Science and Technology Corporation 1 (1.4) Clinical Topic Areas Primary Care 15 (20.3) Cardiovascular … artifact MITRE March - September 2017 AllianceChicago Statin Use for the Primary Prevention of Cardiovascular … Counseling to Promote a Healthful Diet and Physical Activity for CVD Prevention in Adults with Cardiovascular
  10. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2017_Core_Weighted.PDF
    January 01, 2017 - PERC CARDIOVASC PROC W DRUG-ELUTING STENT W MCC OR 4+ VESSELS/STENTS 79,400 0.22% 246: PERCUTANEOUS CARDIOVASCULAR … PERC CARDIOVASC PROC W NON-DRUG-ELUTING STENT W MCC OR 4+ VES/STENTS 8,100 0.02% 248: PERCUTANEOUS CARDIOVASCULAR … AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 33,870 0.09% 270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 44,215 0.12% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 37,220 0.10% 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 16,305 0.05% 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W
  11. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_V2.PDF
    January 01, 2019 - PACEMAKER IMPLANT W/O CC/MCC 6,005 0.08% 245: AICD GENERATOR PROCEDURES 994 0.01% 246: PERCUTANEOUS CARDIOVASCULAR … 24,585 0.35% 247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 54,474 0.77% 248: PERCUTANEOUS CARDIOVASCULAR … : AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 6,624 0.09% 270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 9,861 0.14% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 8,064 0.11% 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 3,207 0.05% 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W
  12. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
    June 26, 2018 - Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the … use, rheumatoid arthritis, alcohol use, hormone replacement therapy, i asthma, endrocrine disease, cardiovascular … 1.01 (95% CI, 0.98-1.05); 13 trials, n = 20,485 d No statistically significant differences for cardiovascular … discontinuations, serious adverse events, and upper GI tract events; inconsistent and imprecise for cardiovascular … bisphosphonates for discontinuation, serious adverse events, and upper gastrointestinal events; insufficient for cardiovascular
  13. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_Core_Weighted_V2.PDF
    January 01, 2019 - PACEMAKER IMPLANT W/O CC/MCC 31,544 0.09% 245: AICD GENERATOR PROCEDURES 5,171 0.01% 246: PERCUTANEOUS CARDIOVASCULAR … 123,463 0.35% 247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 281,990 0.80% 248: PERCUTANEOUS CARDIOVASCULAR … AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 34,999 0.10% 270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 46,432 0.13% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 40,801 0.12% 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 16,462 0.05% 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W
  14. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_CORE_V2.PDF
    January 01, 2019 - PACEMAKER IMPLANT W/O CC/MCC 17,878 0.10% 245: AICD GENERATOR PROCEDURES 2,913 0.02% 246: PERCUTANEOUS CARDIOVASCULAR … 68,419 0.38% 247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 155,954 0.86% 248: PERCUTANEOUS CARDIOVASCULAR … AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 18,694 0.10% 270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 24,937 0.14% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 22,044 0.12% 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 8,870 0.05% 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W
  15. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core.PDF
    January 01, 2018 - PACEMAKER IMPLANT W/O CC/MCC 18,042 0.10% 245: AICD GENERATOR PROCEDURES 3,288 0.02% 246: PERCUTANEOUS CARDIOVASCULAR … 62,623 0.35% 247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 150,877 0.85% 248: PERCUTANEOUS CARDIOVASCULAR … AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 18,641 0.11% 270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 22,693 0.13% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 20,637 0.12% 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 8,400 0.05% 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W
  16. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_V2.PDF
    January 01, 2019 - PACEMAKER IMPLANT W/O CC/MCC 102 0.00% 245: AICD GENERATOR PROCEDURES 86 0.00% 246: PERCUTANEOUS CARDIOVASCULAR … MCC OR 22 0.00% 247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 18 0.00% 248: PERCUTANEOUS CARDIOVASCULAR … 269: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 629 0.02% 270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 2,060 0.07% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 888 0.03% 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 357 0.01% 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W MCC
  17. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
    April 15, 2013 - These trials also provide estimates of harm, including thromboembolic events, cardiovascular disease … Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. … Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women … Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the … Year-by-year analysis of cardiovascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
    April 01, 2022 - mechanism vs. opioid agonist and mortality, falls/fracture, hospitalization for adverse event, or cardiovascular … studies 1 retrospective cohort study (n=77,697) found tramadol associated with decreased risk of cardiovascular … hospitalizations compared with opioid agonists.6 Tramadol was associated with slightly decreased risk of cardiovascular … harms, falls, fractures, motor vehicle accidents, B-2 endocrinological harms, infections, cardiovascular … (gastrointestinal, somnolence, pruritus, dizziness, headache, fracture, motor vehicle accidents, cardiovascular
  19. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Core.PDF
    January 01, 2011 - 106: CORONARY BYPASS W PTCA 1,306 0.02% 108: OTHER CARDIOTHORACIC PROCEDURES 5,482 0.07% 110: MAJOR CARDIOVASCULAR … PROCEDURES W CC 22,618 0.28% 111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 5,532 0.07% 113: AMPUTATION … PERCUTANEOUS CARDIOVASC PROC W NON-DRUG-ELUTING STENT W/O MAJ CV DX 6,201 0.08% 557: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX 45,785 0.57% 558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 3,903 0.05% 63: Other non-OR therapeutic cardiovascular procedures 14,615 0.18% 64: Bone
  20. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Core.PDF
    January 01, 2009 - PROCEDURES W CC 3,426 0.10% 111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 1,091 0.03% 113: AMPUTATION … 18, 2011 38 Frequency Distribution for DRG24 DRG24 Frequency Percent of Total 557: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX <= 10 *.**% 558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … 0.00% 61: Other OR procedures on vessels other than head and neck 8,588 0.25% 62: Other diagnostic cardiovascular … procedures 543 0.02% 63: Other non-OR therapeutic cardiovascular procedures 996 0.03% 64: Bone marrow